ANIP
ANI Pharmaceuticals Inc
78.90$
+3.6%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +8.2% | +13.2% | +27.7% | +4.5% | +6.1% | +1.0% | +67.3% | -1.5% | +19.0% | +41.9% | +12.2% | |
| – | -5.4% | -46.5% | +27.8% | +16.2% | +22.8% | -9.3% | +88.9% | +7.0% | +51.0% | +1.5% | +42.7% | |
| – | -8.5% | -82.3% | +13.8% | +38.1% | +44.9% | -87.4% | +1,175.4% | -51.9% | +358.5% | -34.5% | +97.1% | |
| – | -8.5% | -82.3% | +13.8% | +38.1% | +44.9% | -87.4% | +1,175.4% | -51.9% | +358.5% | -31.6% | +88.9% | |
| – | +26.8% | +109.3% | +28.1% | +10.3% | +11.2% | +32.8% | +34.2% | +28.7% | -2.0% | +36.8% | +26.8% | |
| – | +78.1% | +95.6% | +44.1% | +7.4% | +18.9% | +26.2% | +34.4% | +29.0% | +5.5% | +23.0% | +4.6% | |
| – | +36.5% | +54.2% | +85.5% | +86.7% | +6.5% | +1.8% | +27.6% | -17.9% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +94.8% | +0.0% | +0.0% | +679.0% | +1.2% | +0.0% | +112.6% | +4.2% | |
| – | +57.8% | +164.8% | +30.7% | -12.3% | -10.5% | +4.5% | +56.0% | -14.4% | -16.9% | +159.2% | -11.5% | |
| – | +1.0% | +22.4% | +54.9% | -1.7% | +4.6% | +8.8% | +55.5% | +2.1% | +6.0% | +91.4% | +5.2% | |
| – | -11.2% | +171.8% | +22.8% | +322.0% | -62.7% | +27.4% | +11.4% | +13.6% | +46.3% | +33.1% | +43.6% | |
| – | +6.5% | +6.4% | -97.2% | +3,351.2% | -91.4% | +33.2% | -93.6% | +0.0% | +0.0% | +979.1% | +88.3% | |
| – | -22.2% | +64.0% | +7.1% | +144.7% | +64.4% | -22.9% | +104.0% | +27.6% | +25.2% | +24.5% | +37.1% | |
| – | +2.5% | +6.4% | +6.3% | -47.5% | +161.2% | -1.9% | +66.2% | -0.3% | -0.3% | +115.9% | -2.5% | |
| – | +14.5% | +6.0% | +3.0% | +12.9% | +7.9% | -8.0% | +83.3% | -5.6% | +35.2% | -6.4% | +26.2% | |
| – | – | – | – | – | +53.1% | -128.3% | – | – | – | – | – | |
| – | +4.6% | +0.1% | -0.2% | +1.9% | +2.3% | -0.6% | +5.3% | +29.1% | +11.9% | +6.2% | +9.9% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.